tiprankstipranks
Trending News
More News >
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market
Advertisement

Black Diamond Therapeutics (BDTX) Ratios

Compare
1,567 Followers

Black Diamond Therapeutics Ratios

BDTX's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, BDTX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.94 6.82 8.37 8.87 22.48
Quick Ratio
8.94 6.82 8.37 8.87 22.48
Cash Ratio
1.99 2.86 2.25 2.78 2.43
Solvency Ratio
0.69 -1.96 -2.00 -0.25 -2.96
Operating Cash Flow Ratio
1.37 -3.40 -5.58 -4.24 -3.67
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 107.41M$ 92.20M$ 87.15M$ -281.72M$ 297.64M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.16 0.18 0.11 0.03
Debt-to-Equity Ratio
0.13 0.22 -0.08 -0.12 -0.07
Debt-to-Capital Ratio
0.11 0.18 -0.09 -0.13 -0.08
Long-Term Debt-to-Capital Ratio
0.11 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.25 1.36 -0.47 -1.02 -2.79
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 -64.88K
Interest Coverage Ratio
0.00 0.00 0.00 0.00 -69.57K
Debt to Market Cap
0.06 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.28 0.58 0.77 0.79 0.27
Net Debt to EBITDA
-0.99 0.36 0.07 0.29 0.39
Profitability Margins
Gross Profit Margin
99.51%0.00%0.00%0.00%0.00%
EBIT Margin
36.44%0.00%0.00%0.00%0.00%
EBITDA Margin
21.23%0.00%0.00%0.00%0.00%
Operating Profit Margin
16.81%0.00%0.00%0.00%0.00%
Pretax Profit Margin
30.49%0.00%0.00%0.00%0.00%
Net Profit Margin
30.49%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
42.54%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%95.05%98.09%97.36%
EBT Per EBIT
181.31%95.35%95.79%98.99%96.67%
Return on Assets (ROA)
13.63%-51.99%-54.09%-49.74%-19.86%
Return on Equity (ROE)
17.78%-70.62%25.23%50.53%55.39%
Return on Capital Employed (ROCE)
8.34%-62.24%-65.84%-56.63%-22.05%
Return on Invested Capital (ROIC)
8.34%-60.87%-61.35%-55.47%-21.40%
Return on Tangible Assets
13.63%-51.99%-54.09%-49.74%-19.86%
Earnings Yield
8.17%-66.75%-129.26%-63.87%-6.21%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.09 0.19 1.73 0.54 0.24
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
3.96 0.00 0.00 0.00 0.00
Asset Turnover
0.45 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
0.56 0.00 0.00 0.00 0.00
Cash Conversion Cycle
-4.14K -1.94K -211.58 -676.16 -1.54K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
4.14K 1.94K 211.58 676.16 1.54K
Operating Cycle
0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
0.37 -1.52 -2.34 -2.77 -1.58
Free Cash Flow Per Share
0.37 -1.52 -2.35 -2.84 -1.59
CapEx Per Share
0.00 <0.01 <0.01 0.07 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.03 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 -2.02K -443.14 -36.95 -367.23
Capital Expenditure Coverage Ratio
0.00 -2.02K -443.14 -36.95 -367.23
Operating Cash Flow Coverage Ratio
1.33 -2.64 -3.02 -3.52 -5.97
Operating Cash Flow to Sales Ratio
0.30 0.00 0.00 0.00 0.00
Free Cash Flow Yield
8.12%-54.04%-130.42%-53.33%-4.96%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.25 -1.50 -0.77 -1.57 -16.11
Price-to-Sales (P/S) Ratio
3.73 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
2.09 1.06 -0.20 -0.79 -8.92
Price-to-Free Cash Flow (P/FCF) Ratio
12.34 -1.85 -0.77 -1.88 -20.17
Price-to-Operating Cash Flow Ratio
12.34 -1.85 -0.77 -1.93 -20.23
Price-to-Earnings Growth (PEG) Ratio
0.24 0.08 0.02 -0.02 -0.22
Price-to-Fair Value
2.09 1.06 -0.20 -0.79 -8.92
Enterprise Value Multiple
16.60 -1.08 -0.64 -1.23 -15.44
Enterprise Value
248.21M 92.59M 59.21M 155.55M 1.03B
EV to EBITDA
16.58 -1.08 -0.64 -1.23 -15.44
EV to Sales
3.52 0.00 0.00 0.00 0.00
EV to Free Cash Flow
11.63 -1.39 -0.69 -1.51 -19.68
EV to Operating Cash Flow
11.63 -1.39 -0.70 -1.55 -19.73
Tangible Book Value Per Share
2.22 2.66 3.18 -6.74 9.35
Shareholders’ Equity Per Share
2.22 2.66 -9.22 -6.74 -3.59
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.05 0.02 0.03
Revenue Per Share
1.24 0.00 0.00 0.00 0.00
Net Income Per Share
0.38 -1.88 -2.33 -3.40 -1.99
Tax Burden
1.00 1.00 0.95 0.98 0.97
Interest Burden
0.84 0.95 0.96 0.99 1.00
Research & Development to Revenue
0.56 0.00 0.00 0.00 0.00
SG&A to Revenue
0.26 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.10 0.00 0.00 0.00 0.00
Income Quality
0.99 0.81 0.93 0.80 0.78
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis